Chamber and committees

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

Written questions must be answered within 10 working days (20 working days during recess)
Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.

Find out more about parliamentary questions

Filter your results Hide all filters

Displaying 790 questions Show Answers

Order by |

Question reference: S5W-31306

Asked by: Richard Leonard, MSP for Central Scotland, Scottish Labour
Date lodged: Wednesday, 26 August 2020
Current Status: Answered by Joe FitzPatrick on 9 September 2020

To ask the Scottish Government how much it has spent on developing the substance misuse electronic assessment tool, Drug and Alcohol Intervention Service (DAISy); what the final estimated cost is, and how this compares with the original estimate.

The development and maintenance costs associated with the Drug and Alcohol Information System (DAISy) remain in line with the allocated budgets. Development costs up to 31 March 2021 are estimated to total £529,100 followed by recurring annual expenditure for further development and maintenance set at £120,000 per year since 2017-18 on a recurring basis.

During the development, data provision has been ensured form the continuation of the existing data tools at no additional cost.

Question reference: S5F-04351

Asked by: Richard Leonard, MSP for Central Scotland, Scottish Labour
Date lodged: Monday, 07 September 2020
Current Status: Taken in the Chamber on 10 September 2020

Question to be taken in Chamber.

Question reference: S5F-04329

Asked by: Richard Leonard, MSP for Central Scotland, Scottish Labour
Date lodged: Monday, 31 August 2020
Current Status: Taken in the Chamber on 2 September 2020

Question to be taken in Chamber.

Question reference: S5W-31307

Asked by: Richard Leonard, MSP for Central Scotland, Scottish Labour
Date lodged: Thursday, 20 August 2020
Current Status: Answered by Joe FitzPatrick on 28 August 2020

To ask the Scottish Government whether NHS Information Services Division (ISD) will publish draft details of the substance misuse electronic assessment tool, Drug and Alcohol Intervention Service (DAISy) before beta testing to allow frontline drug workers and managers and people in treatment or recovery to comment before its finalisation.

Question reference: S5W-31308

Asked by: Richard Leonard, MSP for Central Scotland, Scottish Labour
Date lodged: Thursday, 20 August 2020
Current Status: Answered by Joe FitzPatrick on 28 August 2020

To ask the Scottish Government which drug teams are or have been involved in the beta testing of the substance misuse electronic assessment tool, Drug and Alcohol Intervention Service (DAISy).

Question reference: S5W-31304

Asked by: Richard Leonard, MSP for Central Scotland, Scottish Labour
Date lodged: Thursday, 20 August 2020
Current Status: Answered by Joe FitzPatrick on 28 August 2020

To ask the Scottish Government for what reason the substance misuse electronic assessment tool, Drug and Alcohol Intervention Service (DAISy), is not yet operational.

The development has taken longer than originally envisaged due to the complexity of the system, and to ensure that the necessary standards in relation to security, reliability and sustainability are met.

The Drug and Alcohol Information System (DAISy) is expected to be implemented across Scotland by the end of 2020.

DAISy is a new development which will collect the data required for reporting on drug and alcohol treatment and outcomes at a local and national level. It will replace two existing data collection systems, the Scottish Drug Misuse Database and the Drug and Alcohol Treatment Waiting Times database, and will also include data on alcohol treatment and outcomes which is currently not collected.

Details of the Drug and Alcohol Information System (DAISy) have been shared and discussed with members of the DAISy Implementation Group which includes Alcohol & Drug Partnership service representation from across Scotland throughout the development.

DAISy Implementation Group members advise on the implementation of DAISy to ensure that the new system meets Alcohol & Drug Partnership service requirements, recommend system features that would enhance data management, recording and the quality of data to ensure that the system meet local needs.

Details of the Drug and Alcohol Information System (DAISy) have been shared and discussed with members of the DAISy Implementation Group which includes representation from each Alcohol & Drug Partnership across Scotland.

Group members advise on the implementation of DAISy to ensure that the new system meets Alcohol & Drug Partnership service requirements, recommend system features that would enhance data management, recording and the quality of data and directly liaise with Alcohol & Drug Partnerships and Services to ensure that the system meet local needs.

A series of walk-through sessions have been undertaken with Alcohol & Drug Partnership service representatives to demonstrate the layout and functionality of DAISy in order to assist with local planning and implementation.

Question reference: S5W-31057

Asked by: Richard Leonard, MSP for Central Scotland, Scottish Labour
Date lodged: Monday, 03 August 2020
Current Status: Answered by Jeane Freeman on 26 August 2020

To ask the Scottish Government, in light of the publication in The Lancet of research showing the benefit of the Cytosponge TFF3 test in diagnosing Barrett’s oesophagus early and in savings on endoscopies, and in light of the reported backlog in endoscopies due to the COVID-19 pandemic, what steps it is taking to ensure the test's widespread and rapid introduction in hospitals and primary care.

An agreement has been reached with all NHS Scotland Health Boards to progress implementation of this non-aerosol generating procedure at pace. To aid this implementation, training of nursing staff has been scheduled and Boards are now making the necessary provision for a state of readiness. The initial implementation of this will have a secondary care focus to support the recovery of endoscopy services.

Alongside the implementation of this procedure, as part of NHS Scotland’s COVID-19 response, a rapid roll-out of Colon Capsule Endoscopy (CCE) is underway, working closely with territorial Health Boards, industry partners and NSS. CCE adoption offers the opportunity to provide further capacity for bowel cancer diagnostics and supporting endoscopy services recovery. Funding has been made available to Health Boards to adopt CCE as part of the recently approved Endoscopy Recovery Plan.

Question reference: S5W-30909

Asked by: Richard Leonard, MSP for Central Scotland, Scottish Labour
Date lodged: Friday, 24 July 2020
Current Status: Answered by Jeane Freeman on 26 August 2020

To ask the Scottish Government when the NHS Louisa Jordan hospital will open to patients, and which procedures will take place there.

A successful pilot at the NHS Louisa Jordan has seen 400 patients receive orthopaedic and plastic surgery outpatient consultations since the start of July. Following the successful three-week project by NHS Lanarkshire, plans are now in place to expand the services offered at the hospital in August and increase the number of patients it can receive daily from health boards across Scotland. The new services to be offered include key diagnostics such as X-rays, CT scanning and ultrasounds, as well as speciality dermatology appointments .

Question reference: S5W-30911

Asked by: Richard Leonard, MSP for Central Scotland, Scottish Labour
Date lodged: Friday, 24 July 2020
Current Status: Answered by Jeane Freeman on 26 August 2020

To ask the Scottish Government how many staff are currently working at the NHS Louisa Jordan hospital; what their job titles are, and how many staff have worked there in each month since the building work was officially completed.

The number of staff working at NHS Louisa Jordan has varied since the building work officially completed and is dependent on what activities are taking place on the site and the requirements for the continued oversight of the facility.

An organisational structure was established to support the NHS Louisa Jordan Hospital operating for its original Covid purpose. The roles in that structure reflected the corporate and clinical governance arrangements which are required within a hospital setting and are outlined in Annex A.

It should be noted however the majority of these roles were not full-time appointments with the requirements of some of the roles equating to one or two days input per week.

As well as identifying staff for these jobs, over 200 staff from across NHS Scotland have been inducted to be able to perform front line clinical roles. Plans are in place to be able to stand the NHS Louisa Jordan up for its original purpose within seven days should that be required.

A slightly reframed executive structure has been put in place to support the NHS Louisa Jordan in its current role, including the provision of elective outpatient appointments and is outlined in Annex B. That structure is supplemented as required by NHS Boards to deliver the services they provide at NHS Louisa Jordan.

In addition to NHS Staff, the facility requires support from SEC staff, G4S security and FM support through SERCO.

ANNEX A – CORPORATE AND CLINICAL GOVERNANCE ROLES AT NHS LOUISA JORDAN TO SUPPORT COVID

Chief Executive

Medical Director

Nurse Director

Communications Director

Health Facilities Director

Head of Facilities/Contracts

Programme Management Director

Workforce Director

Associate Director of Workforce

HR Business Partner

HR Manager

Health and Safety Advisor

Head of Occupational Health

Deputy Medical Director

Associate Medical Director

Chief of Medicine

Chief Pharmacist

Lead Clinician

Chief Nurse Operational/Tactical

Associate Chief Nurse

Associate Nurse Director – Quality, Safety and Professional Practice

Associate Nurse Director – Nursing/Patient Flow

Chief AHP

Pastoral Care

Quality and Safety Advisor

Infection Control Advisor

Finance Director

Clinical Operations Director

e-Health Lead

Radiography Lead

Business and Continuity Advisor

General Operations Director

Strategic Operations Manager

ANNEX B – CORPORATE AND CLINICAL GOVERNANCE ROLES AT NHS LOUISA JORDAN TO SUPPORT EDUCATION AND ELECTIVE SERVICES

Chief Executive

Medical Director

Nurse Director

Communications Director

Health Facilities Director

Head of Facilities/Contracts

Programme Management Director

Workforce Director

Associate Director of Workforce

Health and Safety Advisor

Chief Pharmacist

Chief Nurse Operational/Tactical

Chief AHP

Infection Control Advisor

Finance Director

Clinical Operations Director

e-Health Lead

Radiography Lead

Business and Continuity Advisor

General Operations Director

Question reference: S5F-04303

Asked by: Richard Leonard, MSP for Central Scotland, Scottish Labour
Date lodged: Monday, 24 August 2020
Current Status: Taken in the Chamber on 26 August 2020

Question to be taken in Chamber.